CStone Pharmaceuticals (CSPHF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 463.84 Million | 481.36 Million | 243.71 Million | 1.03 Billion | - | 12.55 Million |
| Cost of Revenue | 159.54 Million | 202.98 Million | 106.83 Million | 241.42 Million | - | - |
| Gross Profit | 304.29 Million | 278.37 Million | 136.88 Million | 797.41 Million | - | 12.55 Million |
| Operating Expenses | 304.29 Million | 1.18 Billion | 1.93 Billion | 1.86 Billion | 1.73 Billion | 1.05 Billion |
| Selling, General and Administrative Expenses | 248.06 Million | 390.47 Million | 472.99 Million | 228.88 Million | 86.22 Million | 81.38 Million |
| Research and Development Expenses | 527.79 Million | 614.16 Million | 1.3 Billion | 1.4 Billion | 1.39 Billion | 850.19 Million |
| Other Expenses | - | 72 Thousand | 47 Thousand | - | - | - |
| Cost and Expenses | 1.04 Billion | 1.38 Billion | 2.03 Billion | 2.1 Billion | 1.73 Billion | 1.05 Billion |
| Operating Income | -534.6 Million | -832.27 Million | -1.85 Billion | -1.22 Billion | -1.56 Billion | -921.6 Million |
| Interest Expense | 11.81 Million | 8.47 Million | 2.24 Million | 1.32 Million | 303 Thousand | - |
| Income Tax Expense | - | 44.31 Million | 22.42 Million | 14.59 Million | 11.4 Million | -47.85 Million |
| Earnings before Tax | -367.23 Million | -902.67 Million | -1.92 Billion | -1.22 Billion | -2.3 Billion | -1.79 Billion |
| Net Income | -367.23 Million | -902.67 Million | -1.92 Billion | -1.22 Billion | -2.3 Billion | -1.74 Billion |
| Earnings Per Share Basic | -0.29 | -0.77 | -1.65 | -1.17 | -2.66 | -1.79 |
| Earnings Per Share Diluted | -0.29 | -0.77 | -1.65 | -1.17 | -2.66 | -1.77 |
| Weighted Average Shares Outstanding | 1.26 Billion | 1.17 Billion | 1.16 Billion | 1.04 Billion | 866.72 Million | 973.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.26 Billion | 1.17 Billion | 1.16 Billion | 1.04 Billion | 866.72 Million | 984.05 Million |
| Gross Margin | 0.66 | 0.58 | 0.56 | 0.77 | - | 1.00 |
| EBIT Margin | -0.64 | -1.64 | -7.51 | -1.16 | - | -73.02 |
| Profit Margin | -0.79 | -1.88 | -7.88 | -1.18 | - | -139.07 |
| EBITDA | -297.22 Million | -849.66 Million | -1.83 Billion | -1.2 Billion | -1.73 Billion | -1.02 Billion |
| Earnings Before Tax Margin | -1.15 | -1.73 | -7.60 | -1.18 | - | -73.43 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 27.99 Million | 463.84 Million | 37.72 Million | 481.36 Million | 31.54 Million | 40.26 Million |
| Cost of Revenue | 8.44 Million | 159.54 Million | 16.95 Million | 202.98 Million | 17.38 Million | 15.89 Million |
| Gross Profit | 19.54 Million | 304.29 Million | 20.76 Million | 278.37 Million | 14.15 Million | 24.37 Million |
| Operating Expenses | 68.17 Million | 884.14 Million | 57.4 Million | 1.18 Billion | 90.76 Million | 82.64 Million |
| Selling, General and Administrative Expenses | 21 Million | - | 30.45 Million | - | 40.85 Million | 41.62 Million |
| Research and Development Expenses | 47.16 Million | - | 26.94 Million | - | 49.91 Million | 41.01 Million |
| Other Expenses | - | -8000.00 | - | 72 Thousand | - | - |
| Cost and Expenses | 76.62 Million | 1.04 Billion | 74.36 Million | 1.38 Billion | 108.15 Million | 98.53 Million |
| Operating Income | -48.63 Million | -534.6 Million | -36.64 Million | -832.27 Million | -76.61 Million | -58.26 Million |
| Interest Expense | 822.28 Thousand | 11.81 Million | 847.47 Thousand | 8.47 Million | 795.89 Thousand | 451.67 Thousand |
| Income Tax Expense | 1.00 | 58.02 Million | - | 44.31 Million | 2.00 | - |
| Earnings before Tax | -21.85 Million | -367.23 Million | -30.18 Million | -902.67 Million | -77.72 Million | -55.62 Million |
| Net Income | -21.85 Million | -367.23 Million | -30.18 Million | -902.67 Million | -77.72 Million | -55.62 Million |
| Earnings Per Share Basic | -0.02 | - | -0.02 | - | -0.06 | -0.05 |
| Earnings Per Share Diluted | -0.02 | - | -0.02 | - | -0.06 | -0.05 |
| Weighted Average Shares Outstanding | 1.27 Billion | 1.26 Billion | 1.25 Billion | 1.17 Billion | 1.19 Billion | 1.17 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.27 Billion | 1.26 Billion | 1.25 Billion | 1.17 Billion | 1.19 Billion | 1.17 Billion |
| Gross Margin | 0.70 | 0.66 | 0.55 | 0.58 | 0.45 | 0.61 |
| EBIT Margin | -1.59 | - | -0.86 | - | -2.30 | -1.35 |
| Profit Margin | -0.78 | -0.79 | -0.80 | -1.88 | -2.46 | -1.38 |
| EBITDA | -44.54 Million | - | -32.51 Million | - | -72.48 Million | -54.22 Million |
| Earnings Before Tax Margin | -1.74 | -1.15 | -0.97 | -1.73 | -2.43 | -1.45 |
1050
5842
CAH
KAL
GBCI
TPTW